Works matching DE "MONOCLONAL gammopathies"


Results: 1927
    1
    2

    Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

    Published in:
    2021
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • de Tute, Ruth M.;
    • Hockaday, Anna;
    • Collett, Corinne;
    • Jones, John R.;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Rocci, Alberto;
    • Snowden, John A.;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Gregory, Walter M.;
    • Kaiser, Martin F.
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants.

    Published in:
    Vaccines, 2024, v. 12, n. 5, p. 518, doi. 10.3390/vaccines12050518
    By:
    • Wagner, Angelika;
    • Garner-Spitzer, Erika;
    • Auer, Claudia;
    • Gattinger, Pia;
    • Zwazl, Ines;
    • Platzer, René;
    • Orola-Taus, Maria;
    • Pichler, Peter;
    • Amman, Fabian;
    • Bergthaler, Andreas;
    • Huppa, Johannes B.;
    • Stockinger, Hannes;
    • Zielinski, Christoph C.;
    • Valenta, Rudolf;
    • Kundi, Michael;
    • Wiedermann, Ursula
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    COVID‐19 in solid organ transplant recipients.

    Published in:
    Transplant Infectious Disease, 2021, v. 23, n. 1, p. 1, doi. 10.1111/tid.13419
    By:
    • Giorgakis, Emmanouil;
    • Zehtaban, Shannon P.;
    • Stevens, Amanda E.;
    • Bhusal, Sushma;
    • Burdine, Lyle
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965905
    By:
    • Landeira-Viñuela, Alicia;
    • Arias-Hidalgo, Carlota;
    • Juanes-Velasco, Pablo;
    • Alcoceba, Miguel;
    • Navarro-Bailón, Almudena;
    • Eduardo Pedreira, Carlos;
    • Lecrevisse, Quentin;
    • Díaz-Muñoz, Laura;
    • Sánchez-Santos, José Manuel;
    • Hernández, Ángela-Patricia;
    • García-Vaquero, Marina L.;
    • Góngora, Rafael;
    • Las Rivas, Javier De;
    • González, Marcos;
    • Orfao, Alberto;
    • Fuentes, Manuel
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 4, p. 705, doi. 10.1002/ijc.34209
    By:
    • Zaleska, Joanna;
    • Kwasnik, Paulina;
    • Paziewska, Magdalena;
    • Purkot, Joanna;
    • Szabelak, Aleksandra;
    • Jurek, Mateusz;
    • Masny, Natalia;
    • Dziatkiewicz, Izabela;
    • Pronobis‐Szczylik, Bartosz;
    • Piebiak, Agnieszka;
    • Szymczyk, Agnieszka;
    • Jarosz‐Chudzik, Katarzyna;
    • Bolkun, Lukasz;
    • Kozlowska, Katarzyna;
    • Piszcz, Jaroslaw;
    • Subocz, Edyta;
    • Halka, Janusz;
    • Bator, Michal;
    • Kalicinska, Elzbieta;
    • Wrobel, Tomasz
    Publication type:
    Article
    50